← brief for 2026-08-12 · Regeneration & devices

Engineered Mesenchymal Stem Cell-Derived Extracellular Vesicles as Antifibrotic Nanotherapeutics for Chronic Kidney Disease.

Article D Peer reviewed Preclinical

Key takeaways

Researchers built tiny particles released by stem cells and used them to fight kidney scarring. Early tests suggest the particles can lower scarring in chronic kidney disease. This was lab and animal work, not people yet.

Who did this work

Zhang W · Xu S · Cao Z · Jin W · Deng S · Zhou Q · Xia X · Wang X

Source

Article · PubMed, fibrosis reversal · 2026 Aug 11
https://pubmed.ncbi.nlm.nih.gov/42581571/